195 related articles for article (PubMed ID: 28484271)
41. Poor Yield of Routine Transthyretin Screening in Patients with Idiopathic Neuropathy.
Namiranian D; Chalk C; Massie R
Can J Neurol Sci; 2020 Nov; 47(6):816-819. PubMed ID: 32493526
[TBL] [Abstract][Full Text] [Related]
42. Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation.
Okumura K; Yamashita T; Masuda T; Misumi Y; Ueda A; Ueda M; Obayashi K; Jono H; Yamashita S; Inomata Y; Ando Y
Amyloid; 2016; 23(1):39-45. PubMed ID: 26763274
[TBL] [Abstract][Full Text] [Related]
43. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
44. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis.
Tojo K; Sekijima Y; Kelly JW; Ikeda S
Neurosci Res; 2006 Dec; 56(4):441-9. PubMed ID: 17028027
[TBL] [Abstract][Full Text] [Related]
45. Analysis of mitochondrial haplogroups associated with TTR Val30Ala familial amyloidotic polyneuropathy in Chinese patients.
Liu JY; Jiang XM; Zhang M; Guo YJ
Int J Neurosci; 2012 Dec; 122(12):716-8. PubMed ID: 22784244
[TBL] [Abstract][Full Text] [Related]
46. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
Berg I; Thor S; Hammarström P
Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
[TBL] [Abstract][Full Text] [Related]
47. Refine penetrance estimates in the main pathogenic variants of transthyretin hereditary (familial) amyloid polyneuropathy (TTR-FAP) using a new non-parametric approach (NPSE).
Gorram F; Alarcon F; Perdry H; Hébrard B; Damy T; Fanen P; Funalot B; Nuel G; Planté-Bordeneuve V
Amyloid; 2017 Mar; 24(sup1):115-116. PubMed ID: 28434346
[No Abstract] [Full Text] [Related]
48. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
Dardiotis E; Koutsou P; Zamba-Papanicolaou E; Vonta I; Hadjivassiliou M; Hadjigeorgiou G; Cariolou M; Christodoulou K; Kyriakides T
J Neurol Sci; 2009 Sep; 284(1-2):158-62. PubMed ID: 19493541
[TBL] [Abstract][Full Text] [Related]
49. Finding of vascular amyloid TTR in inferior nasal concha in a patient with FAP TTRVal30Met.
Munar-Ques M; Martinez-Nadal J; Torres-Rovira JJ; Sole M; Zabay-Becerril JM; Mulet-Ferrer JM
Amyloid; 2008 Dec; 15(4):272-4. PubMed ID: 19065300
[TBL] [Abstract][Full Text] [Related]
50. Clinical and genetic findings in eight Israeli patients with transthyretin-associated familial amyloid polyneuropathy.
Leibou L; Frand J; Sadeh M; Lossos A; Kremer E; Livneh A; Yarnitsky D; Herman O; Dabby R
Isr Med Assoc J; 2012 Nov; 14(11):662-5. PubMed ID: 23240369
[TBL] [Abstract][Full Text] [Related]
51. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
[TBL] [Abstract][Full Text] [Related]
52. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M
J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945
[TBL] [Abstract][Full Text] [Related]
53. Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine.
Obayashi K; Tasaki M; Jono H; Ueda M; Shinriki S; Misumi Y; Yamashita T; Oshima T; Nakamura T; Ikemizu S; Anan I; Suhr O; Ando Y
Clin Chim Acta; 2013 Apr; 419():127-31. PubMed ID: 23462670
[TBL] [Abstract][Full Text] [Related]
54. Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden.
Soares ML; Coelho T; Sousa A; Holmgren G; Saraiva MJ; Kastner DL; Buxbaum JN
Eur J Hum Genet; 2004 Mar; 12(3):225-37. PubMed ID: 14673473
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
Ikeda K; Kano O; Ito H; Kawase Y; Iwamoto K; Sato R; Sekine T; Nagata R; Nakamura Y; Hirayama T; Iwasaki Y
Neurology; 2008 Apr; 70(17):1576; author reply 1576-7. PubMed ID: 18427077
[No Abstract] [Full Text] [Related]
56. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.
Sousa MM; Saraiva MJ
Prog Neurobiol; 2003 Dec; 71(5):385-400. PubMed ID: 14757117
[TBL] [Abstract][Full Text] [Related]
57. Characterisation of serum transthyretin by electrospray ionisation-ion mobility mass spectrometry: Application to familial amyloidotic polyneuropathy type I (FAP-I).
Pont L; Benavente F; Vilaseca M; Giménez E; Sanz-Nebot V
Talanta; 2015 Nov; 144():1216-24. PubMed ID: 26452950
[TBL] [Abstract][Full Text] [Related]
58. In vitro modelling of familial amyloidotic polyneuropathy allows quantitative detection of transthyretin amyloid fibril-like structures in hepatic derivatives of patient-specific induced pluripotent stem cells.
Hoepfner J; Kleinsorge M; Papp O; Alfken S; Heiringhoff R; Pich A; Sauer V; Zibert A; Göhring G; Schmidt H; Sgodda M; Cantz T
Biol Chem; 2017 Jul; 398(8):939-954. PubMed ID: 28051995
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
Planté-Bordeneuve V; Ferreira A; Lalu T; Zaros C; Lacroix C; Adams D; Said G
Neurology; 2007 Aug; 69(7):693-8. PubMed ID: 17698792
[TBL] [Abstract][Full Text] [Related]
60. Chapter 17: Transthyretin: an enhancer of nerve regeneration.
Fleming CE; Mar FM; Franquinho F; Sousa MM
Int Rev Neurobiol; 2009; 87():337-46. PubMed ID: 19682646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
